Event Start Date:
June 4, 2026
Event End Date:
June 4, 2026
Event Venue:


JBI gLOCAL Solution Room

Evidence on Prevention, Screening, and Management of Cervical Cancer

Date
04 June 2026
Mode
Virtual
07:00 – 13:15  Ghana
09:00 – 15:15  South Africa
12:30 – 18:30  India

The JBI gLOCAL Solution Room is a week-long global series of locally hosted, interactive events designed to provide pragmatic solutions to challenges in getting evidence into practice, bringing together clinicians, academics and policymakers to discuss how global evidence informs local practice and how local experience shapes global thinking in evidence-based healthcare. JBI explicitly frames “gLOCALization” as the simultaneous global and local nature of evidence generation, synthesis, transfer and implementation, emphasizing that evidence must be adapted to specific contexts given differences in economics, policy, systems and culture.

Despite remarkable advances in medical science, far too many lives are still lost each year due to gaps in awareness, access to vaccination, screening, and timely treatment. This gLOCAL solution provides a vital platform for sharing knowledge, strengthening collaboration, and renewing our collective commitment to ensuring that no woman dies from a disease we have the tools to prevent and cure. This gLOCAL solution focuses on the importance of eliminating cervical cancer, a disease that remains a significant yet largely preventable threat to women’s health worldwide.

JBI Evidence-Based Indigenous Health India
JBI Ekurhuleni Clinical Research Centre, South Africa
JBI Evidence-Based Practice Research Group Ghana

08:30 – 09:00
Arrival & Registration

1
Session 1: Introduction and Overview
Session Chair: Dr Sajda Khatoon (India)
Time (GH / SA / IN) Talk Country
07:00–07:10 GH 09:00–09:10 SA 12:30–12:40 IN
Welcome and Introduction
Dr Sajda Khatoon
India
07:10–07:40 GH 09:10–09:40 SA 12:40–13:10 IN
Introduction to JBI
Prof Zoe Jordan — JBIC, Adelaide, Australia
Australia
07:40–08:05 GH 09:40–10:05 SA 13:10–13:35 IN
Introduction to JBI directors
JBI Centre Directors — South Africa, India, Cameroon & Ghana
Multi
08:05–08:30 GH 10:05–10:30 SA 13:35–14:00 IN
Keynote Speaker: Guideline on cervical cancer screening for HIV patients Keynote
Professor Greta Dreyer — University of Pretoria, South Africa; President, International Gynecologic Cancer Society
South Africa

2
Session 2: Screening to Treatment — Integrated Approaches to Cervical Cancer Prevention
Session Chairs: Dr Bernard Uzabakiriho (South Africa) & Dr Krishantha Pillay (South Africa)
Time (GH / SA / IN) Talk Country
08:30–08:45 GH 10:30–10:45 SA 14:00–14:15 IN
Prevention & Early detection of HPV lesions: HPV Screen-And-Treat (SAT) with Point of Care testing, same-day results and treatment
Dr KK Khulu — University of the Witwatersrand
South Africa
08:45–09:00 GH 10:45–11:00 SA 14:15–14:30 IN
HPV Testing vs Cytology: Evidence for Primary Screening
Prof Matthys Cornelis van Aardt — University of Pretoria
South Africa
09:00–09:15 GH 11:00–11:15 SA 14:30–14:45 IN
Eliminating cervical cancer in Ghana: Aligning national prevention efforts with global elimination targets
Prof Edward Tieru Dassah — Kwame Nkrumah University of Science and Technology
Ghana
09:15–09:30 GH 11:15–11:30 SA 14:45–15:00 IN
Management of Precancerous Lesions — LLETZ: safety issues, post-LLETZ management, management of complications
Dr E Mnisi — University of Pretoria
South Africa
09:30–09:45 GH 11:30–11:45 SA 15:00–15:15 IN
Perceptions and Practices relating to the Human Papilloma Virus among caregivers and adolescents: Implication for HPV vaccine acceptance
Dr Asahngwa Constantine — University of Yaoundé 1, Cameroon
Cameroon
09:45–10:00 GH 11:45–12:00 SA 15:15–15:30 IN Q & A — Session chairs
— Health break: 15 minutes —

3
Session 3: Treatment Challenges and Innovative Approaches for Managing Complexity of Cervical Cancer Care
Session Chairs: Dr Raj Shankar Ghosh (India) & Prof Yeetey Enuameh (Ghana)
Time (GH / SA / IN) Talk Country
10:15–10:30 GH 12:15–12:30 SA 15:45–16:00 IN
Radiotherapy treatment resistance in cervical cancer
Prof Shenaaz Bassa — University of Pretoria
South Africa
10:30–10:45 GH 12:30–12:45 SA 16:00–16:15 IN
Cervical Cancer in Pregnant WLHIV: Case series
Dr B. Uzabakiriho — University of the Witwatersrand
South Africa
10:45–11:00 GH 12:45–13:00 SA 16:15–16:30 IN
Role of telemedicine for management of cervical cancer
Dr Krishantha Pillay — University of Pretoria
South Africa
11:00–11:15 GH 13:00–13:15 SA 16:30–16:45 IN
India's Journey in Cervical Cancer Care: Integrating Prevention, Screening, and Treatment
Dr Raj Shankar Ghosh
India
11:15–11:30 GH 13:15–13:30 SA 16:45–17:00 IN Q & A — Session chairs
— Health break: 15 minutes —

4
Session 4: Role of Data, Surveillance, and Health Communication for Strengthening Control of Cervical Cancer
Session Chair: Prof Shenaaz Bassa (South Africa)
Time (GH / SA / IN) Talk Country
11:45–12:00 GH 13:45–14:00 SA 17:15–17:30 IN
Role of Cancer registry for management of cervical cancer
Dr Mazvita Muchengeti — South African National Cancer Registry
South Africa
12:00–12:15 GH 14:00–14:15 SA 17:30–17:45 IN
Surveillance of cervical cancer in a central hospital in South Africa
Dr Nozipho Magagula — University of Pretoria
South Africa
12:15–12:30 GH 14:15–14:30 SA 17:45–18:00 IN
Health communication in cervical cancer
Dr Kaushik Ghosh — Fellow, CPHR
India
12:30–12:45 GH 14:30–14:45 SA 18:00–18:15 IN Q & A — Session chair
12:45–13:15 GH 14:45–15:15 SA 18:15–18:30 IN
Way forward & closure
Dr Paramita Bhattacharya
India

Register Here